靶向T细胞的显像放射性药物综述
该叙述性综述总结了用于T细胞及其亚群显像的主要策略,聚焦自身免疫病与免疫肿瘤学中的临床应用。文章讨论了SPECT与PET放射性药物研发进展、临床转化面临的挑战,以及T细胞显像推动精准医学的潜力。
要点
- T细胞显像可无创可视化并定量肿瘤微环境或自身免疫炎症部位的T细胞。
- CD3、CD8和CD4等表面标志物是免疫显像的主要分子靶点。
- 该领域仍面临临床转化挑战,但有望改善患者结局并革新疾病管理。
核心结论
- T细胞显像正在成为早期疾病检测、个体化免疫治疗与治疗监测的关键工具,推动精准医学。
- T细胞显像有望显著改善患者结局并革新自身免疫病与免疫肿瘤学的管理。
研究设计与样本
- 叙述性综述,概述迄今用于T细胞及其亚群显像的主要策略。
- 文章还讨论将这些方法成功转化至临床实践的进展与挑战。
主要发现
- 体内追踪T淋巴细胞可加深对自身免疫病与癌症中复杂免疫景观的理解。
- T细胞显像可提供对免疫系统机制、通路、分子相互作用及动态特性的新认识。
- 已有大量工作致力于开发高灵敏度、高特异性的SPECT与PET放射性药物。
- 这些工具旨在无创可视化并定量关键靶点,评估肿瘤微环境或自身免疫炎症部位T细胞的功能状态。
关键数值与推荐
- T淋巴细胞提供多个可用于免疫显像的分子靶点,包括已充分表征的CD3、CD8和CD4表面标志物。
临床怎么用
- T细胞显像可用于早期疾病检测、个体化免疫治疗及治疗监测。
- 该技术可无创评估肿瘤微环境或自身免疫炎症部位的T细胞功能状态。
局限性
- 文章指出将这些T细胞显像方法成功转化至临床实践仍存在挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In vivo tracking T-lymphocytes is dramatically advancing our understanding of the complex immune landscape in a wide spectrum of autoimmune and cancer diseases. By providing new insights into intricate mechanisms, pathways, molecular interactions and dynamic nature of immune system, this approach paves the way for personalized therapies, tailored to individual patient need. Imaging T-cells is, indeed, emerging as a crucial tool not only for early disease detection, but also for personalized immune-therapy and treatment monitoring, thus enabling a "precision medicine". T-lymphocytes offers several accessible molecular targets suitable for immune-imaging, including the well-characterized CD3, CD8 and CD4 surface markers. Consequently, significant efforts have been, and currently are, devoted to develop highly sensitive and specific radiopharmaceuticals for single photon emission tomography (SPECT), positron emission tomography (PET). These advanced tools aim to non-invasively visualize and quantify these key targets and to assess the functional status of T-lymphocytes within tumor microenvironment or sites of autoimmune inflammation. This narrative review aims at providing a deep overview of the main strategies adopted so far for imaging T-cells and their subsets, emphasizing current and prospective clinical applications in autoimmune diseases and immune-oncology. Furthermore, advancements and challenges in successfully translating these approaches into clinical practice will be also discussed. We will discuss the great potential of T-cells imaging to significantly improve patient's outcome and revolutionize the management of these challangind diseases.
引用
- Lauri C, Aarntzen E, Glaudemans AW, et al. Radiopharmaceuticals for imaging T-cells. Semin Nucl Med. 2026. PMID: 42049550. doi:10.1053/j.semnuclmed.2026.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。